HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion
- PMID: 11873082
- DOI: 10.1097/00126334-200203010-00013
HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion
Abstract
Homozygosity for the 32 base-pair deletion (Delta32/Delta32) in the CCR5 coreceptor gene is associated with incomplete HIV-1 resistance. Six HIV-1-infected Delta32/Delta32 patients have been reported. We report 2 additional Delta32/Delta32-infected individuals, among 106 seroconverters in a vaccine preparedness study. Like the previous 6, these individuals experienced rapid CD4 decline. However, taken together, the 8 patients have neither uniformly high virus load nor rapid progression to AIDS. We obtained five virus isolates from 1 patient at 5, 6, 7, 10, and 12 months after the estimated time of infection. The earliest isolate exhibits the syncytium-inducing (SI) phenotype and exclusive use of the CXCR4 coreceptor, suggesting acquisition of HIV-1 through this coreceptor. Of the remaining 104 seroconverters, 8 were CCR5-Delta32/+ and 96 were CCR5-+/+. Three CCR5-+/+ seroconverters who showed the uncommon pattern of early SI virus and rapid CD4 decline had uniformly high viral load and more heterogeneous coreceptor usage. These results further support the conclusion that Delta32-mediated resistance is incomplete and is associated with acquisition of exclusively-X4 variants of HIV-1. The pathogenic potential of these viruses may be different from late-stage X4 virus or early X4 virus acquired by individuals with other CCR5 genotypes.
Similar articles
-
MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.AIDS. 1998 May 7;12(7):729-36. doi: 10.1097/00002030-199807000-00009. AIDS. 1998. PMID: 9619804
-
Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.J Virol. 1998 Nov;72(11):9307-12. doi: 10.1128/JVI.72.11.9307-9312.1998. J Virol. 1998. PMID: 9765480 Free PMC article.
-
Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.AIDS. 2015 May 15;29(8):867-76. doi: 10.1097/QAD.0000000000000629. AIDS. 2015. PMID: 25730507 Free PMC article.
-
HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.AIDS Rev. 2017 Dec;19(4):219-230. AIDS Rev. 2017. PMID: 28534889 Review.
-
HIV-1 coreceptor usage, transmission, and disease progression.Curr HIV Res. 2003 Apr;1(2):217-27. doi: 10.2174/1570162033485357. Curr HIV Res. 2003. PMID: 15043204 Review.
Cited by
-
HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells.Cell Host Microbe. 2011 Mar 17;9(3):223-234. doi: 10.1016/j.chom.2011.02.005. Cell Host Microbe. 2011. PMID: 21402361 Free PMC article.
-
CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effects.J Virol. 2008 Mar;82(5):2418-26. doi: 10.1128/JVI.01596-07. Epub 2007 Dec 19. J Virol. 2008. PMID: 18094161 Free PMC article.
-
Cord blood stem cell therapy for acquired immune deficiency syndrome.Stem Cells Dev. 2009 Jan-Feb;18(1):1-2. doi: 10.1089/scd.2008.0304. Stem Cells Dev. 2009. PMID: 19018697 Free PMC article.
-
CCR5Delta32 genotypes in a German HIV-1 seroconverter cohort and report of HIV-1 infection in a CCR5Delta32 homozygous individual.PLoS One. 2008 Jul 23;3(7):e2747. doi: 10.1371/journal.pone.0002747. PLoS One. 2008. PMID: 18648518 Free PMC article.
-
Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.J Virol. 2006 Apr;80(7):3684-91. doi: 10.1128/JVI.80.7.3684-3691.2006. J Virol. 2006. PMID: 16537640 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials